Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD), as it aims for a launch in the middle of ...
Until now, if you were seated at your Sega Genesis and wanted to check your stock portfolio, you were out of luck. You had to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results